A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Blokhin's Russian Cancer Research Center, Moscow, Russia
Study leads
Mikhail Fedyanin MD
Principal Investigator
Blokhin's Russian Cancer Research Center